Franklin Resources Inc Vista Gen Therapeutics, Inc. Transaction History

Franklin Resources Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.07 $49,338 - $377,085	-352,416 Reduced 3.73%	9,096,538 $1.38 Million
Q2 2022 Aug 11, 2022	SELL	$0.88 - $1.73 $432,593 - $850,438	-491,583 Reduced 4.95%	9,448,954 $8.32 Million
Q1 2022 May 13, 2022	SELL	$1.14 - $2.09 $202,306 - $370,895	-177,462 Reduced 1.75%	9,940,537 $12.3 Million
Q4 2021 Feb 11, 2022	SELL	$1.67 - $2.76 $731 - $1,208	-438 Reduced -0.0%	10,117,999 $19.7 Million
Q3 2021 Nov 12, 2021	BUY	$2.62 - $3.45 $465,836 - $613,410	177,800 Added 1.79%	10,118,437 $27.7 Million

Q2 2021 Aug 13, 2021	SELL	$1.96 - $3.15 $1.81 Million - $2.91 Million	-925,300 Reduced 8.52%	9,940,637 $31.3 Million
Q1 2021 May 13, 2021	BUY	$1.89 - $2.96 $8.74 Million - $13.7 Million	4,625,553 Added 74.12%	10,865,937 $23.1 Million
Q4 2020 Feb 10, 2021	BUY	$0.65 - $1.94 $4.06 Million - $12.1 Million	6,240,384 New	6,240,384 $12.1 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.